Syngenta Launches Isopyrazam With First Registration In The UK

BASEL, Switzerland, March 31 --

• Broad spectrum fungicide with new mode of action
• Applications on multiple crops; initial launch on cereals
• Complements Syngenta's world-leading fungicide portfolio

Syngenta announced today the first European registration of the new fungicide isopyrazam, which is expected to enhance significantly its market position, notably in cereals. Isopyrazam has a new mode of action and is the first active ingredient from Syngenta's pipeline of next generation fungicides. Isopyrazam will deliver outstanding performance on a wide range of diseases in many crops. Registrations will be sought globally for fruits and vegetables as well as for cereals.

John Atkin, Chief Operating Officer of Syngenta Crop Protection, said: "This initial launch in barley will set new standards of disease control and yield response, improving grower profitability. Isopyrazam will play an important role in reinforcing Syngenta's global leadership in fungicides."

Isopyrazam will be sold in the UK on winter and spring barley, under the brand BONTIMA®, for use in the 2010 season.

Syngenta is one of the world's leading companies with more than 25,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com or www.growmorefromless.com.

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

    
    
    Syngenta International AG
    
    Media Office
    CH-4002 Basel
    Switzerland
    Tel:    [phone]
    Fax:    [phone]
    
    www.syngenta.com
    
    
    Media contact:
    
    Medard Schoenmaeckers 
    Switzerland   [phone]   
    
    
    Analyst/Investor contacts:
    
    Jennifer Gough
    Switzerland   [phone]
    USA           [phone]
    
    John Hudson
    Switzerland   [phone]
    USA           [phone]

SOURCE Syngenta

>To order reprints of this article, click here: Reprints